These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia. Profaci CP; Krolikowski KA; Olszewski RT; Neale JH Psychopharmacology (Berl); 2011 Jul; 216(2):235-43. PubMed ID: 21327758 [TBL] [Abstract][Full Text] [Related]
7. Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophrenia. Zuo D; Bzdega T; Olszewski RT; Moffett JR; Neale JH J Biol Chem; 2012 Jun; 287(26):21773-82. PubMed ID: 22570482 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action? Ghose S; Gleason KA; Potts BW; Lewis-Amezcua K; Tamminga CA Am J Psychiatry; 2009 Jul; 166(7):812-20. PubMed ID: 19487395 [TBL] [Abstract][Full Text] [Related]
9. Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation. Gray L; van den Buuse M; Scarr E; Dean B; Hannan AJ Int J Neuropsychopharmacol; 2009 Feb; 12(1):45-60. PubMed ID: 18593507 [TBL] [Abstract][Full Text] [Related]
10. Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3. Berent-Spillson A; Robinson AM; Golovoy D; Slusher B; Rojas C; Russell JW J Neurochem; 2004 Apr; 89(1):90-9. PubMed ID: 15030392 [TBL] [Abstract][Full Text] [Related]
11. The astrocyte surface NAAG receptor and NAAG peptidase signaling complex as a therapeutic target. Baslow MH Drug News Perspect; 2008 Jun; 21(5):251-7. PubMed ID: 18596989 [TBL] [Abstract][Full Text] [Related]
12. Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats. Yamamoto T; Saito O; Aoe T; Bartolozzi A; Sarva J; Zhou J; Kozikowski A; Wroblewska B; Bzdega T; Neale JH Eur J Neurosci; 2007 Jan; 25(1):147-58. PubMed ID: 17241276 [TBL] [Abstract][Full Text] [Related]
13. Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration. Nagel J; Belozertseva I; Greco S; Kashkin V; Malyshkin A; Jirgensons A; Shekunova E; Eilbacher B; Bespalov A; Danysz W Neuropharmacology; 2006 Dec; 51(7-8):1163-71. PubMed ID: 16926034 [TBL] [Abstract][Full Text] [Related]
14. Mutual activation of glutamatergic mGlu Cieślik P; Woźniak M; Rook JM; Tantawy MN; Conn PJ; Acher F; Tokarski K; Kusek M; Pilc A; Wierońska JM Psychopharmacology (Berl); 2018 Oct; 235(10):2897-2913. PubMed ID: 30054675 [TBL] [Abstract][Full Text] [Related]
15. mGluR3 knockout mice show a working memory defect and an enhanced response to MK-801 in the T- and Y-maze cognitive tests. Lainiola M; Procaccini C; Linden AM Behav Brain Res; 2014 Jun; 266():94-103. PubMed ID: 24631392 [TBL] [Abstract][Full Text] [Related]
16. 2-PMPA, a NAAG peptidase inhibitor, attenuates magnetic resonance BOLD signals in brain of anesthetized mice: evidence of a link between neuron NAAG release and hyperemia. Baslow MH; Dyakin VV; Nowak KL; Hungund BL; Guilfoyle DN J Mol Neurosci; 2005; 26(1):1-15. PubMed ID: 15968081 [TBL] [Abstract][Full Text] [Related]
17. Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice. Galici R; Jones CK; Hemstapat K; Nong Y; Echemendia NG; Williams LC; de Paulis T; Conn PJ J Pharmacol Exp Ther; 2006 Jul; 318(1):173-85. PubMed ID: 16608916 [TBL] [Abstract][Full Text] [Related]
18. Prefrontal dysfunction and a monkey model of schizophrenia. Mao P; Cui D; Zhao XD; Ma YY Neurosci Bull; 2015 Apr; 31(2):235-41. PubMed ID: 25822218 [TBL] [Abstract][Full Text] [Related]
19. Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia. Fraley ME Expert Opin Ther Pat; 2009 Sep; 19(9):1259-75. PubMed ID: 19552508 [TBL] [Abstract][Full Text] [Related]
20. Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): efficacy in an animal model for schizophrenia. Govek SP; Bonnefous C; Hutchinson JH; Kamenecka T; McQuiston J; Pracitto R; Zhao LX; Gardner MF; James JK; Daggett LP; Rowe BA; Schaffhauser H; Bristow LJ; Campbell UC; Rodriguez DE; Vernier JM Bioorg Med Chem Lett; 2005 Sep; 15(18):4068-72. PubMed ID: 16005222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]